Purkiss Capital Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Hold
25,086
0.09% 164
2026
Q1
$244K Hold
25,086
0.11% 142
2025
Q4
$240K Sell
25,086
-300
-1% -$3.05K 0.11% 150
2025
Q3
$248K Buy
25,386
+482
+2% +$3.71K 0.12% 140
2025
Q2
$151K Buy
24,904
+3,275
+15% +$24.6K 0.08% 149
2025
Q1
$268K Buy
21,629
+10,900
+102% +$154K 0.2% 86
2024
Q4
$149K Buy
+10,729
New +$169K 0.13% 98

Other funds holding PRTA

Purkiss Capital Advisors's PRTA Position: Q2 2026 in Review

Purkiss Capital Advisors held its Prothena Corp (PRTA) position steady in Q2 2026 at 25,086 shares worth $246K. The position accounts for 0.09% of the portfolio, ranked #164.

Purkiss Capital Advisors first reported a position in PRTA in Q4 2024 and has held it in 7 quarters since. The position peaked at $268K in Q1 2025. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Purkiss Capital Advisors held 25,086 shares of Prothena Corp worth $246K as of Q2 2026.
  • Purkiss Capital Advisors left its Prothena Corp share count unchanged in Q2 2026.
  • Prothena Corp made up 0.09% of Purkiss Capital Advisors's portfolio in Q2 2026, its #164 holding.
  • Purkiss Capital Advisors first reported a position in Prothena Corp in Q4 2024 and has held it in 7 quarters since.
  • Purkiss Capital Advisors's Prothena Corp position peaked at $268K in Q1 2025.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Purkiss Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.